PROCEPT BioRobotics Corporation (PRCT) NASDAQ
28.78
+0.43(+1.52%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
28.78
+0.43(+1.52%)
Currency In USD
| Previous Close | 28.35 |
| Open | 28.39 |
| Day High | 29.74 |
| Day Low | 28.38 |
| 52-Week High | 64.92 |
| 52-Week Low | 19.35 |
| Volume | 1.29M |
| Average Volume | 1.44M |
| Market Cap | 1.64B |
| PE | -15.73 |
| EPS | -1.83 |
| Moving Average 50 Days | 25.57 |
| Moving Average 200 Days | 30.62 |
| Change | 0.43 |
PROCEPT BioRobotics® Hosts 2026 Investor Day to Detail Multi-year Financial Outlook and Strategic Plan for Long-Term Growth
GlobeNewswire Inc.
Feb 26, 2026 12:55 PM GMT
Company outlines path to leadership in BPH, including near-term focus on procedure growth through patient-centric solutions and increased organizational disciplineStrong revenue outlook, procedure growth, expanding margins, and path to profitabilityL
PROCEPT BioRobotics® Announces Updated Dates for 4Q25 Earnings Conference Call and Investor Day
GlobeNewswire Inc.
Feb 23, 2026 9:03 PM GMT
SAN JOSE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced tha
PROCEPT BioRobotics® to Attend the TD Cowen 46th Annual Health Care Conference and the 2026 Leerink Global Healthcare Conference
GlobeNewswire Inc.
Feb 04, 2026 9:03 PM GMT
SAN JOSE, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today that members of